
Number of publications published per year by De Man, Robert A.. (Source : PubMed)

Distribution of publications types for De Man, Robert A.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Gastroenterology
2010;138;2

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.
Hepatology
2010;51;1


Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.
Gastroenterology
2009;137;5
Hepatocellular adenoma: cost-effectiveness of different treatment strategies.
Radiology
2009;252;3
Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
Hepatology
2009;50;3
Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?
Vaccine
2009;27;27
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.
J. Hepatol.
2009;50;4

A rare cause of large liver cysts.
Am. J. Gastroenterol.
2009;104;4
[Improvement of 5 year survival rate after liver resection for colorectal metastases between 1984-2006]
Ned Tijdschr Geneeskd
2009;153;11

Autoimmune haemolytic anaemia due to chronic hepatitis C virus infection treated with prednisone, pegylated interferon and ribavirin.
Neth J Med
2009;67;3
[ See timeline ] [ See all publications ]
means that De Man, Robert A. has 33 papers cited a least 33 times - methodology
Afd. Heelkunde, Erasmus MC, Rotterdam.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.